Business

Eli Lilly Acquires AtaiBeckley

Updated 2026-07-16 10:55 UTC 1 source Positive

Pharmaceutical giant Eli Lilly is acquiring psychedelics company AtaiBeckley for $2.8 billion, gaining access to experimental drugs based on DMT and MDMA.

Coverage timeline — 1 article

CNBC

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.

2026-07-16 10:48 UTC